S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT‐NAÏVE EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF THE PHASE 3, DOUBLE‐BLIND, PLACEBO‐CONTROLLED CLL12 TRIAL.
| Autor: | Langerbeins, Petra, Robrecht, Sandra, Nieper, Pascal, Cramer, Paula, Fürstenau, Moritz, Al‐Sawaf, Othman, Fink, Anna‐Maria, Kreuzer, Karl‐Anton, Vehling‐Kaiser, Ursula, Tausch, Eugen, Schneider, Christof, Müller, Lothar, Eckart, Michael, Schlag, Rudolf, Freier, Werner, Gaska, Tobias, Balser, Christina, Reiser, Marcel, Stauch, Martina, Wendtner, Clemens |
|---|---|
| Zdroj: | HemaSphere; 2023 Supplement 3, Vol. 7, p1-3, 3p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Plný text